RESUMO
The paper presents a new model of secondary injuries after traumatic brain injury. The model is based on the cultivation of rat embryonic fibroblasts reprogrammed to a neuronal phenotype in the presence of cerebrospinal fluid from injured rats. The presented model was used to test the therapeutic effect of inducers of the synthesis of chaperones from the classes of pyrrolylazines and indolylazines, which have neuroprotective properties.
Assuntos
Lesões Encefálicas Traumáticas , Lesões Encefálicas , Ratos , Animais , Lesões Encefálicas/líquido cefalorraquidiano , Lesões Encefálicas/complicações , Lesões Encefálicas/terapia , NeurôniosRESUMO
The stress-inducible 70 kDa heat shock protein (Hsp70) can exert a protective effect on endotoxemia and sepsis due to its ability to interact with immune cells and modulate the immune response. However, it remains unknown whether Hsp70 is able to relieve endotoxemia-induced fever. We carried out a comparative study of the effects of preventive administration of the human recombinant Hsp70 (HSPA1A) on lipopolysaccharide (LPS)-induced endotoxemia in pigeons and rats with preimplanted electrodes and thermistors for recording the thermoregulation parameters (brain temperature, peripheral vasomotor reaction, muscular contractile activity). Additionally, we analyzed the dynamics of the white blood cell (WBC) count in rats under the same conditions. It was found that preventive administration of Hsp70 relieves the LPS-induced febrile reaction in pigeons and rats and accelerates the restoration of the WBC count in rats. The data obtained suggest that these warm-blooded animals share a common physiological mechanism that underlies the protective effect of Hsp70.
RESUMO
The heat shock protein Hsp70 is involved in cell defense from various types of stress, including the proteotoxic stress, which occurs during the development of many neurodegenerative diseases. This work presents data on the detection of small molecules, derivatives of indolyl- and pyrrolylazines, which can activate the synthesis of Hsp70 and cause its accumulation in the cell. The toxicity level of the new Hsp70 synthesis inducers was evaluated, and the safety of these compounds was demonstrated in experiments on SH-SY5Y neuroblastoma cell line. Derivatives of indolyl- and pyrrolylazines presented in this work can be potential therapeutic agents in models of neurodegenerative diseases that should be studied in more detail.
Assuntos
Proteínas de Choque Térmico HSP70/metabolismo , Indóis/farmacologia , Neuroblastoma/metabolismo , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Pirróis/farmacologia , Linhagem Celular Tumoral , Humanos , Indóis/química , Neuroblastoma/tratamento farmacológico , Neuroblastoma/patologia , Pirróis/químicaAssuntos
Proteínas de Choque Térmico HSP70/metabolismo , Doença de Parkinson/metabolismo , Substância Negra/metabolismo , Animais , Neurônios Dopaminérgicos/metabolismo , Proteínas de Choque Térmico HSP70/genética , Masculino , Doença de Parkinson/patologia , Ratos , Ratos Wistar , Substância Negra/patologiaAssuntos
Proteínas de Choque Térmico HSP70/metabolismo , Sono/fisiologia , Animais , Temperatura Corporal , Eletroencefalografia , Eletromiografia , Eletroculografia , Vetores Genéticos , Proteínas de Choque Térmico HSP70/genética , Imuno-Histoquímica , Lentivirus/genética , Masculino , Microscopia Confocal , Monitorização Ambulatorial , Córtex Motor/metabolismo , Área Pré-Óptica/metabolismo , RNA Interferente Pequeno , Ratos Wistar , Telemetria , Fatores de Tempo , VigíliaAssuntos
Proteínas de Choque Térmico HSP70/uso terapêutico , Fármacos Neuroprotetores/uso terapêutico , Doença de Parkinson Secundária/tratamento farmacológico , Acetilcisteína/análogos & derivados , Acetilcisteína/toxicidade , Animais , Proteínas de Choque Térmico HSP70/farmacocinética , Masculino , Fármacos Neuroprotetores/farmacocinética , Doença de Parkinson Secundária/etiologia , Inibidores de Proteases/toxicidade , Ratos , Ratos WistarRESUMO
For the first time, the biodistribution of recombinant heat shock protein in rhHsp70 rats with grafted intracranial C6 glioma was evaluated. It was assessed using the fluorescent antibody accumulation chaperone rhHsp70 conjugated with fluorochrome Alexa Fluor 555 in tumor cells by intratumoral or intravenous administration. Assessment of the distribution and accumulation of labeled protein was carried out on the model of subcutaneous B16/F10 melanoma in C57BL/6 mice with the use of single-photon emission computer tomography. After 60 minutes after intravenous administration rhHsp70-I123 (20 MBq, 5 mg chaperone) accumulation of the drug mainly in the liver and tumor tissue was showed. The coefficient of the differential accumulation of the labeled protein KDN(tumor/background) was 3.14. It was turned out that comparing the level of fixation of rhHsp70-I123 in the liver and the tumor KDN(tumor/ liver) = 0.76. After 24 hours from the time of injection of rhHsp70-I123 it was observed increase the level of fixation of the labeled protein in the liver and melanoma: KDN(tumor/background) = 3.43; KDN(tumor/liver = 0.78.
Assuntos
Neoplasias Encefálicas/metabolismo , Glioma/metabolismo , Proteínas de Choque Térmico HSP70/metabolismo , Fígado/metabolismo , Melanoma Experimental/metabolismo , Neoplasias Cutâneas/metabolismo , Animais , Corantes Fluorescentes , Proteínas de Choque Térmico HSP70/administração & dosagem , Proteínas de Choque Térmico HSP70/farmacocinética , Injeções Intralesionais , Injeções Intravenosas , Radioisótopos do Iodo , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Neoplasias Experimentais/metabolismo , Ratos , Ratos Wistar , Fatores de Tempo , Distribuição Tecidual , Tomografia Computadorizada de Emissão de Fóton ÚnicoRESUMO
Most neurodegenerative pathologies stem from the formation of aggregates of mutant proteins, causing dysfunction and ultimately neuronal death. This study was aimed at elucidating the role of the protein factors that promote aggregate formation or prevent the process, respectively, glyceraldehyde-3-dehydrogenase (GAPDH) and tissue transglutaminase (tTG) and Hsp70 molecular chaperone. The siRNA technology was used to show that the inhibition of GAPDH expression leads to a 45-50% reduction in the aggregation of mutant huntingtin, with a repeat of 103 glutamine residues in a model of Huntington's disease (HD). Similarly, the blockage of GAPDH synthesis was found for the first time to reduce the degree of aggregation of mutant superoxide dismutase 1 (G93A) in a model of amyotrophic lateral sclerosis (ALS). The treatment of cells that imitate HD and ALS with a pharmacological GAPDH inhibitor, hydroxynonenal, was also shown to reduce the amount of the aggregating material in both disease models. Tissue transglutaminase is another factor that promotes the aggregation of mutant proteins; the inhibition of its activity with cystamine was found to prevent aggregate formation of mutant huntingtin and SOD1. In order to explore the protective function of Hsp70 in the control of the aggregation of mutant huntingtin, a cell model with inducible expression of the chaperone was used. The amount and size of polyglutamine aggregates were reduced by increasing the intracellular content of Hsp70. Thus, pharmacological regulation of the function of three proteins, GAPDH, tTG, and Hsp70, can affect the pathogenesis of two significant neurodegenerative diseases.
RESUMO
Molecular chaperons can effectively activate innate and adaptive anti-tumor immune response. In the model of intracranial glioma C6 in Wistar rats we assessed immunomodulatory activity of recombinant protein Hsp70 in case of local, intratumoral injection. Single intratumoral infusion of chaperone had led to dramatic delay in tumor volume growth (on MRI of rat brain), which was accompanied by increase in survival rates. Incubation of rat spleenocytes with C6 cells elevated the levels of INF-gamma, that shows an immunologically specific T-cell response. With immunohistochemical assay we observed a marked infiltration of the tumor by T-lymphocytes and NK-cells. Thus, purified Hsp70 can efficiently induce innate and adaptive anti-tumor response and could be used as adjuvant in treatment of malignant brain tumors of central nervous system.
Assuntos
Antineoplásicos/farmacologia , Neoplasias Encefálicas/tratamento farmacológico , Neoplasias Encefálicas/imunologia , Glioblastoma/tratamento farmacológico , Glioblastoma/imunologia , Proteínas de Choque Térmico HSP70/farmacologia , Imunidade Adaptativa/efeitos dos fármacos , Adjuvantes Imunológicos/administração & dosagem , Adjuvantes Imunológicos/farmacologia , Animais , Antineoplásicos/administração & dosagem , Modelos Animais de Doenças , Proteínas de Choque Térmico HSP70/administração & dosagem , Imunidade Inata/efeitos dos fármacos , Infusões Intralesionais , Interferon gama/metabolismo , Células Matadoras Naturais/efeitos dos fármacos , Ratos , Ratos Wistar , Proteínas Recombinantes/farmacologia , Análise de Sobrevida , Linfócitos T/efeitos dos fármacos , Células Tumorais CultivadasRESUMO
Data obtained for the last 12 years and modern hypotheses on key function of sleep and the role of Heat Shock Protein 70 kDa (HSP70) molecular chaperones family in sleep modulation are insufficient to determine assotiation of sleep quantity to the level of chaperones in the basic "center" of sleep in the ventrolateral preoptic area (VLPA) of the hypothalamus. In the present study, to reduce the content of Hdj1 major co-chaperone of Hsp70 in the VLPA we employed a novel approach based on lentiviral construction containing specific Hdj1-shRNA. The immunoblotting data showed that in 6 weeks after infection the level of Hdj1 in VLPA was reduced by 80% that was accompanied by a considerable increase in the quantity of slow-wave sleep and a marked decrease in the level of anxiety; earlier we found that elevation of Hsp70 level in the rat brain resulted in similar changes. It is suggested that the increase in quantity of slow wave sleep and the decrease in the level of anxiety can be related to a sustained disorder in the integration between molecular systems based on chaperones Hdj1 and Hsp70 and to a compensatory increase in the Hsp70 chaperone activity/level in VLPA.
Assuntos
Ansiedade/metabolismo , Proteínas de Choque Térmico HSP40/genética , Proteínas de Choque Térmico HSP70/genética , Área Pré-Óptica/metabolismo , RNA Interferente Pequeno/genética , Sono/genética , Animais , Ansiedade/genética , Expressão Gênica , Vetores Genéticos , Proteínas de Choque Térmico HSP40/antagonistas & inibidores , Proteínas de Choque Térmico HSP40/metabolismo , Proteínas de Choque Térmico HSP70/metabolismo , Humanos , Injeções Intraventriculares , Lentivirus/genética , Masculino , Ligação Proteica , Ratos , Ratos WistarRESUMO
In Wistar rats, specific inhibitor UPS lactacystin induced degeneration of 24% of the dopaminergic neurons in the black substance. The work shows that a moderate weakening of the UPS function is characterized by an enhanced activity of the shaperon system. This process seems to restore and maintain population of the dopaminergic neurons.
Assuntos
Proteínas de Choque Térmico HSP70/biossíntese , Neurônios/efeitos dos fármacos , Doença de Parkinson , Complexo de Endopeptidases do Proteassoma/efeitos dos fármacos , Substância Negra/patologia , Tirosina 3-Mono-Oxigenase/biossíntese , Acetilcisteína/análogos & derivados , Acetilcisteína/farmacologia , Envelhecimento/fisiologia , Animais , Proteínas de Bactérias/análise , Biotina/análogos & derivados , Biotina/análise , Western Blotting , Cateterismo , Inibidores de Cisteína Proteinase/farmacologia , Modelos Animais de Doenças , Dopamina/farmacologia , Humanos , Imuno-Histoquímica , Microinjeções , Microscopia Confocal , Neurônios/citologia , Doença de Parkinson/patologia , Doença de Parkinson/fisiopatologia , Complexo de Endopeptidases do Proteassoma/metabolismo , Inibidores de Proteassoma , Ratos , Ratos Wistar , Substância Negra/efeitos dos fármacos , Substância Negra/fisiopatologia , Ubiquitina/antagonistas & inibidores , Ubiquitina/metabolismo , Regulação para CimaRESUMO
Kinetics of the chaperone activity of proteins Hsp70 and Hdj1 were analyzed in human U-937 promonocytes during their response to heat shock or to treatment with the echinochrome triacetyl glucoside derivative U-133. To measure the chaperone activity of both proteins, a special test was developed for their recognition and binding of a denatured protein. Using this test, the chaperone activity could be concurrently estimated in large numbers of cellular or tissue extracts. We also estimated the contents of both chaperones in cells by immunoblotting. The values for contents of Hsp70 and Hdj1 obtained by two independent test systems coincided, and this suggested that the substrate-binding activity could change proportionally to the chaperone content in the protein mixture. Therefore, the test developed by us can be employed for high throughput screening of drugs activating cellular chaperones. The analysis of quantity and activity of two cellular chaperones during the cell response to heat stress or to the drug-like substance U-133 showed that both factors caused the accumulation of chaperones with similar kinetics. We conclude that the efficiency of drug preconditioning could be close to the efficiency of hyperthermia and that the high activity of chaperones could be retained in human cells for no less than 1.5 days.
Assuntos
Glucosídeos/farmacologia , Proteínas de Choque Térmico HSP40/metabolismo , Proteínas de Choque Térmico HSP70/metabolismo , Resposta ao Choque Térmico , Leucemia/metabolismo , Naftoquinonas/farmacologia , Linhagem Celular Tumoral , Proteínas de Choque Térmico HSP40/química , Proteínas de Choque Térmico HSP70/química , Humanos , Cinética , Leucemia/fisiopatologia , Chaperonas Moleculares/química , Chaperonas Moleculares/metabolismo , Ligação Proteica/efeitos dos fármacosRESUMO
Effects of thermal preconditioning universal recognized method of increase in concentration of inducible Heat shock protein 70 kDa (Hsp70i) on characteristics of convulsive activity in Krushinskii-Molodkina (KM) rats with inheritable audiogenic epilepsy were studied. For the first time, it was found that short-term thermal preconditioning (41 degrees C during 5 minutes) increased duration of the latency of audiogenic seizure onset. Thermal preconditioning resulted in an increase in concentration of Hsp70i in amygdale, hypothalamus, midbrain; the uttermost increase was observed in hippocampus and inferior colliculus: the brain areas responsible for initiation of audiogenic seizures. A coincidence was found in the term of increase in concentration of Hsp70i and the latency of seizure onset (on day 4 after thermal preconditioning). Results of this research confirm the proposition that inducible Hsp70i is capable of taking part in the processes of seizure development in rats with inheritable form of audiogenic epilepsy.
Assuntos
Epilepsia Reflexa/fisiopatologia , Proteínas de Choque Térmico HSP70/fisiologia , Temperatura Alta , Convulsões/fisiopatologia , Estimulação Acústica , Animais , Encéfalo/fisiopatologia , Modelos Animais de Doenças , Epilepsia Reflexa/genética , Humanos , Atividade Motora/fisiologia , Ratos , Ratos EndogâmicosRESUMO
Effects of the inhibitor of the expression of Heat shock proteins 70 kDa (Hsp70), quercetin on seizures and movement disorders induced by N-methyl D-aspartate (NMDA) or pentylenetetrazole in adult rats Wistar were investigated using behavioral methods. It was found that intraperitoneal injection of quercetin 4 hours before intraventricular microinjection of NMDA resulted in increased duration of tonic component of seizures, seizure and ataxia symptoms severity. Blockade of the expression of Hsp70 by quercetin increased the duration of clonic and tonic seizures and did not affect severity of seizures and ataxia symptoms, induced by intraperitoneal injection of pentylenetetrazole. Immunoblotting showed that injection of quercetin resulted in reduced content of the inducible form of Hsp70 in the hippocampus, thalamus and corpus callosum. The obtained results indicate proconvulsant effect of quercetin associated with the inhibition of Hsp70 expression. These data suggest involvement of Hp70 in regulation of central mechanisms of behavioral seizures and motor disorders induced by NMDA and pentylenetetrazole in rats.
Assuntos
Antioxidantes/farmacologia , Corpo Caloso/metabolismo , Regulação da Expressão Gênica/efeitos dos fármacos , Hipocampo/metabolismo , Quercetina/farmacologia , Convulsões/metabolismo , Animais , Ataxia/induzido quimicamente , Ataxia/metabolismo , Comportamento Animal/efeitos dos fármacos , Agonistas de Aminoácidos Excitatórios/efeitos adversos , Agonistas de Aminoácidos Excitatórios/farmacologia , Antagonistas GABAérgicos/efeitos adversos , Antagonistas GABAérgicos/farmacologia , Proteínas de Choque Térmico HSP70 , Masculino , N-Metilaspartato/efeitos adversos , N-Metilaspartato/farmacologia , Pentilenotetrazol/efeitos adversos , Pentilenotetrazol/farmacologia , Ratos , Ratos Wistar , Convulsões/induzido quimicamente , Índice de Gravidade de DoençaRESUMO
Hsp70 possesses chaperonic activity, the property associated with the protective function that was demonstrated in experiments on a great number of cell and animal models. Therefore, it seems important to search for the substances able to innocuously elevate the chaperone concentration in an organism cells and tissues. In our work, we screened of more that 60 compounds and found two chemicals, derivatives of shikonin and echinochrome that able to increase the chaperone level in a variety of human cells. It was shown that in human erythroleukemia K562 cells treated with the both substances concomitantly with elevation of Hsp70 level the absolute chaperonic activity was also increased; this can indicate mobilization of the whole cellular chaperonic machinery by above mentioned compounds. Estimating biological activity of the two substances, we demonstrated that treatments of cells by them prior to hard heat stress, hydrogen peroxide or staurosporine reduced cell mortality by 20-50 % depending on a cytotoxic factor. The results show that after simple chemical modifications these compounds might be taken as a basis of pharmaceuticals for therapy of wide range of disorders.
Assuntos
Proteínas de Choque Térmico HSP70/biossíntese , Naftoquinonas/química , Animais , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Medicamentos de Ervas Chinesas/química , Humanos , Células K562 , Lithospermum/química , Naftoquinonas/farmacologia , Biossíntese de Proteínas/efeitos dos fármacos , Ouriços-do-Mar/químicaAssuntos
Proteínas de Choque Térmico HSP70/farmacologia , Lipopolissacarídeos/toxicidade , Ativação de Neutrófilo/efeitos dos fármacos , Animais , Apoptose/efeitos dos fármacos , Antígeno CD11b/metabolismo , Camelus , Infecções por Escherichia coli/imunologia , Infecções por Escherichia coli/prevenção & controle , Humanos , Técnicas In Vitro , Ativação de Neutrófilo/imunologia , Neutrófilos/citologia , Neutrófilos/efeitos dos fármacos , Neutrófilos/imunologia , Espécies Reativas de Oxigênio/metabolismo , Proteínas Recombinantes/farmacologia , Sepse/imunologia , Sepse/prevenção & controleRESUMO
Chaperones constitute a class of proteins able to recognize newly synthesized and(or) damaged polypeptides and to transport these to the sites of their allocation or promote the degradation of irreversibly spoiled ones. The members of Hsp70 family can be classified as the first-discovered chaperones, and to date the chaperonic mechanism based on the proteins is well understood. Using this mechanism Hsp70 executes the dual role: it corrects the structure of nascent and damaged polypeptides or promotes degradation of incorrigible polypeptides. Chaperonic activity appears to form key functions of Hsp70, protective and adjuvant ones. The former is proved in a large amount of experiments both in vitro and in vivo. From the beginning of the 2000th, it has become clear that Hsp70 can be released by cells treated by a number of stressful factors, and exogenous chaperone can influence the cells of innate immunity system proving that the protein uses its protective power already at a level of the whole organism. One of the goals of this review is to describe the functions performed by Hsp70 inside and outside a cell. In a view of its properties Hsp70 can be of significant interest for creation of novel therapeutic technologies. This direction to the practical application of the chaperone is also considered in the review.
Assuntos
Proteínas de Choque Térmico HSP70/metabolismo , Chaperonas Moleculares/metabolismo , Estresse Fisiológico , Animais , Apoptose , Humanos , Doença de Huntington/metabolismo , Doença de Huntington/terapia , Imunidade Inata , Neoplasias/metabolismo , Neoplasias/terapia , Dobramento de Proteína , Transdução de SinaisRESUMO
Immunization of experimental animals with extract or membranes of rat rhabdomyosarcoma RA-2 in combination with pure Hsp70 did not offer any significant effect of protection from subsequent RA-2 cells-stimulated tumor growth. By contrast, immunization with preparations of pure Hsp70 led to a significant decrease in number and size of tumors as well as elevation of concentrations of antibodies against RA-2 cells. Also, enhanced blood levels of Hsp70 involved delayed tumor growth. In vitro tests Hsp70 incubation with RA-2 cells was followed by a 30-35% rise in cytotoxic lymphocytes levels. An ability of pure Hsp70 preparations to stimulate humoral and antitumor response was demonstrated. Hence, they may be used in developing vaccine formulas.
Assuntos
Vacinas Anticâncer/administração & dosagem , Proteínas de Choque Térmico HSP70/administração & dosagem , Proteínas de Choque Térmico HSP70/metabolismo , Rabdomiossarcoma/imunologia , Animais , Vacinas Anticâncer/metabolismo , Modelos Animais de Doenças , Feminino , Proteínas de Choque Térmico HSP70/sangue , Proteínas de Choque Térmico HSP70/imunologia , Masculino , RatosRESUMO
HIF-1alpha is synthesized constutively, however under normoxia it is specifically degraded. Hypoxia blocks the factor degradation, and it activates the transcription of genes whose products control multiple cellular processes. Hsp70 molecular chaperone is known to protect neural cells from the deleterious effects of hypoxic stress, though the mechanism of this action remains elusive. To understand how Hsp70 protects cells affected by hard hypoxia the model cell line was constructed based on human neuroblastoma SK-N-SH cells and over-expressing the chaperone when treated by zinc salt. The cells were shown to be resistant to the treatment by CoCl2 imitating in the experiments the reaction to hypoxia. Life span of HIF-1alpha was elevated in these cells as compared with parental line due to the fact that Hsp70 formed long-time complex with HIF-1alpha. The data show that Hsp70 interferes with signaling pathways of cellular response to hypoxic stress at the level of regulation of HIF-1alpha stability.
Assuntos
Proteínas de Choque Térmico HSP70/fisiologia , Hipóxia/fisiopatologia , Linhagem Celular Tumoral , Cobalto/efeitos adversos , Humanos , Hipóxia/induzido quimicamente , Subunidade alfa do Fator 1 Induzível por Hipóxia/metabolismo , Proteínas Recombinantes/biossíntese , Transdução de Sinais/fisiologiaRESUMO
Studies of expression of molecular chaperones of the family of Heat Shock Proteins 70 kDa (HSP70) in the mouse and rat brain during sleep deprivation do not answer the question whether the HSP70 produce somnogenic effect. In the present work there are studied effects of exogenous Hsp70 that is known to be able to penetrate into living cells in vitro and to acquire properties of endogenous chaperone. Hsp70 was microinjected into the third brain ventricle of rats and pigeons at the beginning of the inactive period of the day when under natural conditions the sleep duration increases and the somato-visceral parameters decrease. Hsp70 was found to enhance this natural process and to produce an additional increase in the total time of slow-wave sleep, a more pronounced inhibition of the muscle contractive activity, and a deeper decrease in the brain temperature. A similarity in effects of Hsp70 in rats and pigeons was revealed. In both species the somnogenic effect of Hsp70 in is realized by activation of mechanisms of maintenance of in longer episodes of in slow-wave sleep. The hypothermic Hsp70 effect seems to be associated with a decrease in the muscle contractive activity level, rather than with an enhancement in peripheral vasodilation and with an increase of heat loss. A hypothesis is put forward that the neuroleptic effect of Hsp70 that includes the somnogenic, myorelaxing, and hypothermic effects is mediated by activation of GABAA receptors of the main inhibitory brain system.